TAK Institutional Ownership & Shareholders

TAKEDA PHARMACEUTIC-SP ADR (TAK) is currently held by 383 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $1.68B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

Capital Research Global Investors is currently the largest disclosed institutional shareholder of TAK tracked by InsiderSet, reporting ownership valued at approximately $309.34M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $403.51M, representing an estimated gain of +30.44% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 61% of the total disclosed TAK value among the investors covered in this analysis. Major shareholders include Capital Research Global Investors, Fmr Llc, Morgan Stanley, and several other long-term asset managers with concentrated positions in TAKEDA PHARMACEUTIC-SP ADR (TAK).

This page ranks the largest institutional TAK shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

383

Total Reported Value

$1.68B

Largest Holder

Capital Research Global Investors

Largest Position

$309.34M

Insider Transactions (90d)

19

Latest Filing Quarter

Q2 2026

New Institutional Positions

56

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Capital Research Global Investors0.04%19,297,680$309,341,810$403,514,489+$94,172,679+30.44%
Fmr Llc0.01%9,599,302$153,876,803$200,721,405+$46,844,602+30.44%
Morgan Stanley0.01%6,994,924$112,128,655$146,263,861+$34,135,206+30.44%
Adage Capital Partners Gp, L.L.C.0.14%6,050,771$96,993,859$126,521,622+$29,527,763+30.44%
Goldman Sachs Group Inc0.01%5,125,032$82,154,258$107,164,419+$25,010,161+30.44%
Brandes Investment Partners, Lp0.51%4,539,347$72,765,928$94,917,746+$22,151,818+30.44%
Arrowstreet Capital, Limited Partnership0.03%3,732,924$59,838,772$78,055,441+$18,216,669+30.44%
Blackrock, Inc.0.00%3,688,166$59,121,313$77,119,551+$17,998,238+30.44%
Renaissance Technologies LLCJim Simons0.06%2,568,000$41,165,040$53,696,880+$12,531,840+30.44%
Qube Research & Technologies Ltd0.04%2,207,432$35,385,135$46,157,403+$10,772,268+30.44%
First Trust Advisors Lp0.02%2,114,912$33,902,011$44,222,810+$10,320,799+30.44%
D. E. Shaw & Co., Inc.0.02%2,049,467$32,852,956$42,854,355+$10,001,399+30.44%
Managed Asset Portfolios, Llc3.34%1,823,884$29,236,866$38,137,414+$8,900,548+30.44%
Northern Trust Corp0.00%1,740,313$27,897,218$36,389,945+$8,492,727+30.44%
Van Eck Associates Corp0.02%1,674,005$26,834,300$35,003,445+$8,169,145+30.44%
Envestnet Asset Management Inc0.01%1,598,174$25,617,763$33,417,818+$7,800,055+30.45%
Aqr Capital Management Llc0.01%1,525,686$24,456,751$31,902,094+$7,445,343+30.44%
Quantinno Capital Management Lp0.03%1,402,650$22,484,494$29,329,412+$6,844,918+30.44%
Wells Fargo & Company/Mn0.00%1,150,820$18,447,659$24,063,646+$5,615,987+30.44%
Millennium Management Llc0.01%1,050,698$16,842,689$21,970,095+$5,127,406+30.44%
Ubs Group Ag0.00%911,319$14,608,444$19,055,680+$4,447,236+30.44%
Creative Planning0.01%708,295$12,883,882$14,810,448+$1,926,566+14.95%
Jpmorgan Chase & Co0.00%744,916$11,903,771$15,576,194+$3,672,423+30.85%
Stifel Financial Corp0.01%722,863$11,587,485$15,115,065+$3,527,580+30.44%
Bnp Paribas Financial Markets0.01%714,143$11,447,712$14,932,730+$3,485,018+30.44%
Royal Bank Of Canada0.00%692,900$11,107,000$14,488,539+$3,381,539+30.45%
Focus Partners Wealth0.01%679,950$10,901,024$14,217,755+$3,316,731+30.43%
Abc Arbitrage Sa1.01%564,472$10,267,746$11,803,110+$1,535,364+14.95%
Charles Schwab Investment Management Inc0.00%619,021$9,922,907$12,943,729+$3,020,822+30.44%
American Century Companies Inc0.00%584,560$9,370,497$12,223,150+$2,852,653+30.44%
Lpl Financial Llc0.00%555,228$8,900,303$11,609,817+$2,709,514+30.44%
Balyasny Asset Management L.P.0.01%511,336$8,196,716$10,692,036+$2,495,320+30.44%
Two Sigma Investments, Lp0.01%485,733$7,786,300$10,156,677+$2,370,377+30.44%
Us Bancorp \De\0.01%466,714$7,481,425$9,758,990+$2,277,565+30.44%
Pfm Health Sciences, Lp0.62%444,173$7,120,093$9,287,657+$2,167,564+30.44%
Bleakley Financial Group, Llc0.09%432,956$6,940,285$9,053,110+$2,112,825+30.44%
Raymond James Financial Inc0.00%408,739$6,552,092$8,546,732+$1,994,640+30.44%
Citigroup Inc0.00%396,457$6,355,206$8,289,916+$1,934,710+30.44%
Federated Hermes, Inc.0.01%376,858$6,041,034$7,880,101+$1,839,067+30.44%
Qrg Capital Management, Inc.0.05%372,752$5,975,215$7,794,244+$1,819,029+30.44%
Ethic Inc.0.07%365,253$5,854,998$7,637,440+$1,782,442+30.44%
Vestmark Advisory Solutions, Inc.0.05%351,770$5,638,878$7,355,511+$1,716,633+30.44%
Assetmark, Inc0.01%289,107$5,258,852$6,045,227+$786,375+14.95%
Mariner, Llc0.01%308,157$4,939,586$6,443,563+$1,503,977+30.45%
Bank Of America Corp0.00%307,312$4,926,218$6,425,894+$1,499,676+30.44%
Pathstone Holdings, Llc0.02%241,293$4,468,746$5,045,437+$576,691+12.90%
Hrt Financial Lp0.01%278,706$4,467,000$5,827,742+$1,360,742+30.46%
Hudson Bay Capital Management Lp0.02%275,000$4,408,250$5,750,250+$1,342,000+30.44%
Hantz Financial Services, Inc.0.06%269,650$4,322,000$5,638,382+$1,316,382+30.46%
Natixis Advisors, Llc0.00%268,328$4,301,000$5,610,738+$1,309,738+30.45%
Showing 50 of 383

Frequently asked questions about TAK

  • Who are the largest institutional holders of TAK?

    The largest institutional holders of TAK reported in the latest SEC Form 13F filings include Capital Research Global Investors, Fmr Llc, Morgan Stanley, Adage Capital Partners Gp, L.L.C., and Goldman Sachs Group Inc. InsiderSet ranks institutional holders by their latest reported TAK position.

  • What is TAK institutional ownership?

    This page tracks TAK positions reported by institutional investment managers through SEC Form 13F. TAKEDA PHARMACEUTIC-SP ADR (TAK) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own TAK?

    InsiderSet currently tracks 383 institutional managers reporting TAK holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of TAK shareholders.

  • How much TAK stock do institutions own?

    Institutional investment managers disclosed approximately $1.68B in TAK holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was TAK institutional ownership last updated?

    The latest TAK institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional TAK holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its TAK position after the reporting date.

  • Are institutions buying or selling TAK?

    Institutional buying and selling can be analyzed by comparing TAK positions across consecutive 13F reporting periods. InsiderSet's TAK Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View TAK ownership changes.

  • How has TAK institutional ownership changed over time?

    InsiderSet tracks TAK institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.